Latest Australian Markets News

Amaero Ltd’s Federal Court-approved re-domiciliation schemes take effect on 11 June 2026, halting ASX trading of existing shares and paving the way for new US HoldCo CDIs to list.

The ACCC has approved Ampol’s acquisition of EG Australia, mandating the sale of 41 overlapping fuel retail sites to Metro Petroleum to maintain competition across 39 local markets.

Janison Education Group has wrapped up its largest FY26 assessment programs including NAPLAN and its first New Zealand Ministry of Education event, while progressing AI capabilities and navigating a $3 million revenue impact from exiting NSW venue hire services.

QuickFee Limited has reported a robust 77% increase in Australian originations for Q4 FY26 to-date, driven by strong Fee Funding and Disbursement Funding growth. The company boosted its Australian credit facility by A$15 million, signalling confidence in its low-risk lending model, while US operations focus on reseller channel expansion amid a product embedding delay.

Acrux has locked in a milestone-based licensing agreement worth up to AUD 5.4 million for Lenzetto®, targeting the Australian menopause therapy market with regulatory and commercial milestones tied to TGA approval and sales performance.

Acrux has amended its licensing agreement with Gedeon Richter to bring its Estradiol spray Lenzetto® to Australia, unlocking up to AUD 5.4 million in milestone payments and addressing a critical shortage in Menopause Hormone Therapy products.

Australian Vintage Limited has locked in a $128 million refinancing deal extending to 2029 and reported a significant cash flow turnaround in FY26, driven by innovation and strategic acquisitions.

PaySauce has successfully launched its Global Payroll Platform in Australia, targeting nearly 700,000 micro-businesses, supported by a $5 million capital raise and steady growth in its New Zealand operations.

EROAD reported flat group revenue of NZD 195.2 million for FY26, driven by strong Australian growth and steady New Zealand performance, offset by a North American decline and a hefty goodwill impairment.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.

Carnegie Clean Energy has dismissed any undisclosed information behind a recent surge in its ASX share price, attributing the spike to increased trading activity on its US OTC market.

Electro Optic Systems (ASX:EOS) has closed its three-year turnaround and is now poised for growth, backed by a landmark high-energy laser contract, a major European acquisition, and a $175 million capital raise.